Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma [Phase 3]
Phase 3 trial comparing Skeletal Targeted Radiotherapy (STR) plus melphalan with stem cell transplant versus melphalan alone in multiple mye…
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma [Phase 1]
A Phase 1 study reports the repeat-dose pharmacokinetics and pharmacodynamics of bortezomib in patients with relapsed multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2009-03-26Clinical Trial Update: VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients With Previously Untreated Multiple Myeloma [Phase 3]
Phase 3 trial comparing Velcade/Melphalan/Prednisone versus Melphalan/Prednisone in newly diagnosed multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-26Clinical Trial Update: A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma [Phase 2]
A Phase 2 study of Panzem (2-methoxyestradiol) in patients with relapsed or plateau phase multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [Phase 3]
This is a Phase 3 trial evaluating combination chemotherapy with or without idarubicin followed by peripheral stem cell transplantation in p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma [Phase 3]
A Phase 3 trial (IFM 2005-01) comparing Velcade plus dexamethasone versus Vincristine/Adriamycin/Dexamethasone in patients with multiple mye…
-
CLINICAL_TRIALS trial_result · 2009-02-04Clinical Trial Update: Comparison of Pharmacokinetics and Pharmacodynamics of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma [Phase 1]
A Phase 1 trial comparing pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of bortezomib in patients …
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma [Phase 3]
A Phase 3 clinical trial investigating the optimal timing of a second autologous peripheral blood stem cell transplantation in patients unde…
-
CLINICAL_TRIALS trial_result · 2009-01-26Clinical Trial Update: Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT [Phase 2]
A Phase II trial evaluating busulfan and fludarabine as preparative conditioning therapy in adults with hematopoietic disorders undergoing m…
-
CLINICAL_TRIALS trial_result · 2009-01-23Clinical Trial Update: Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma [Phase 2]
A Phase 2 study evaluating the combination of arsenic trioxide and thalidomide in patients with refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma [Phase 1, Phase 2]
The clinical trial update reports the termination of a Phase 1/Phase 2 study evaluating Holmium-166-DOTMP for skeletal-targeted radiotherapy…
-
CLINICAL_TRIALS trial_result · 2009-01-07Clinical Trial Update: Behavioral Intervention For BMT/SCT Survivors
A completed clinical trial evaluated a behavioral intervention for bone marrow transplant and stem cell transplant survivors. The study incl…
-
CLINICAL_TRIALS trial_result · 2008-11-27Clinical Trial Update: A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple Myeloma [Phase 3]
Phase 3 trial comparing Thalidomide plus Dexamethasone (Thal-Dex) to DOXIL plus Thal-Dex in newly diagnosed multiple myeloma. The study comp…
-
CLINICAL_TRIALS trial_result · 2008-11-27Clinical Trial Update: Pethema Multiple Myeloma 2000 [Phase 3]
Phase 3 clinical trial update for Pethema Multiple Myeloma 2000; the study has completed.
-
CLINICAL_TRIALS trial_result · 2008-06-20Clinical Trial Update: Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi) [Phase 2]
This entry reports on a Phase 2 clinical trial evaluating tandem autologous and nonmyeloablative allogeneic stem cell transplantation for ne…
-
CLINICAL_TRIALS trial_result · 2008-06-20Clinical Trial Update: Hematopoietic Stem Cell Transplantation in Myeloma [Phase 2, Phase 3]
This clinical trial update discusses a Phase 2/Phase 3 study of hematopoietic stem cell transplantation for multiple myeloma, with the curre…
-
CLINICAL_TRIALS trial_result · 2008-05-20Clinical Trial Update: Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma [Phase 1]
A Phase 1 safety study of the HSP90 inhibitor IPI-504 in patients with relapsed and relapsed-refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-06Clinical Trial Update: VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates [Phase 2]
This clinical trial update reports on a Phase 2 study of first-line therapy for non-transplant-eligible multiple myeloma patients using VTD …
-
CLINICAL_TRIALS trial_result · 2008-03-12Clinical Trial Update: Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM) [Phase 3]
Phase 3 clinical trial update on maintenance therapy with Thalidomide-Dexamethasone after ThaDD in multiple myeloma; the study status is com…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Comparing Treatments for Multiple Myeloma [Phase 2]
The document reports the completion of a Phase 2 trial comparing treatments for multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2008-02-11Clinical Trial Update: Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and Tolerability [Phase 4]
Phase 4 trial evaluating retreatment with Velcade (bortezomib) in multiple myeloma patients to assess efficacy, safety, and tolerability.
-
CLINICAL_TRIALS trial_result · 2008-02-08Clinical Trial Update: Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor [Phase 2]
Phase 2 clinical trial evaluating tacrolimus and mycophenolate mofetil as post-grafting immunosuppression after conditioning with Flu TBI in…
-
CLINICAL_TRIALS trial_result · 2007-12-24Clinical Trial Update: Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma [Phase 1, Phase 2]
This update reports the completion of a Phase 1/2 clinical trial evaluating a vaccination strategy in the peripheral stem cell transplant se…
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma [Phase 1, Phase 2]
This document reports on a phase 1/2 clinical trial evaluating the safety and efficacy of Atiprimod in patients with refractory multiple mye…
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Protein Tyrosine Kinases (PTK) in Multiple Myeloma [Phase 2]
A Phase 2 clinical trial updating the use of protein tyrosine kinase inhibitors in multiple myeloma has completed enrollment and status as r…